Cohance to invest Rs. 23 crore on cGMP Oligonucleotide facility at Hyderabad
This strategic investment strengthens Cohance's integrated oligonucleotide platform
This strategic investment strengthens Cohance's integrated oligonucleotide platform
Minister releases five breakthrough veterinary technologies to strengthen diagnostics and combat antimicrobial resistance
The expansion will bring together talent in AI, data science, and engineering to build the digital foundation needed to accelerate drug discovery and delivery
The company received one observation in the Form-483
The company received 1 (One) observation in the Form-483
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Amgen India investment totals $200 million through 2025
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
Subscribe To Our Newsletter & Stay Updated